Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kevin Charles Gorman Sells 2,274 Shares of Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 2,274 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $134.15, for a total transaction of $305,057.10. Following the completion of the transaction, the chief executive officer now owns […]
More Stories
Release Window for Blue Eye Samurai Season 2? Latest Updates and More
Blue Eye Samurai Season 2 is releasing soon on the most popular streaming platform, Netflix. If you are also a...
What is the Release Date for GTA 6? System Requirements and Updated Features
GTA 6 is finally arriving! After years of delays and speculation, Rockstar finally confirmed the game’s launch by the end...
Upcoming Korean Drama: 100 Days of Deception Release Date, Plot, and More
K-drama fans have been longing for a historical action-romance series. Are you also one of those fans who are desperately...
Custom Web Application Development Process: Benefits, Example, Process, and Cost
For a developing business, it sometimes becomes difficult to manage spreadsheets, teams, and SaaS tools. Are you also facing the...
Netflix’s Upcoming Documentary: A Child of My Own Release Date and More
Are you also interested in watching the real-life documentary? If yes, then this blog is for you. One of the...
Announcement! 1670 Season 4 is Releasing Soon! Release Date, Trailer Updates, and More
Hello! Polish TV series and movie fans. 1670 is going to end soon. With great reviews and huge viewership, the...